Early metabolic changes with thiazide or beta blocker therapy for essential hypertension.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Atenolol (Primary) ; Bendroflumethiazide (Primary)
- Indications Essential hypertension
- Focus Pharmacodynamics
- 14 Jul 2012 Planned patient number for the extension trial (EudraCT2007-005655-42) is now 60.
- 14 Jul 2012 Planned patient number for the extension trial (EudraCT2007-005655-42) is now 60.
- 14 Jul 2012 Actual initiation date for the extension trial (EudraCT2007-005655-42) is now 17 Jan 2008.